Search research articles
Contact Us
Filters
Showing results (51-60 of 407) with videos related to
Page
of 41
Sort By:
BMC Health Services Research
|
May 17, 2017
Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study
Hoang Van Minh, Nguyen Thi Tuyet My, Mark Jit
Eclinicalmedicine
|
April 30, 2024
Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study
Kaja Abbas, Katelyn Jison Yoo, Kiesha Prem, et al.
NPJ Vaccines
|
February 1, 2025
A systematised review and evidence synthesis on the broader societal impact of vaccines against Salmonella
Ezgi Dilek Demirtas, Rosanna Barnard, Jungseok Lee, et al.
Vaccine
|
June 22, 2017
Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis
Sara L Bissett, Anna Godi, Mark Jit, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
May 21, 2021
The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant
David Hodgson, Stefan Flasche, Mark Jit, et al.
Vaccines
|
July 27, 2024
Inequitable Distribution of Global Economic Benefits from Pneumococcal Conjugate Vaccination
Fulgence Niyibitegeka, Fiona M Russell, Mark Jit, et al.
Science Translational Medicine
|
August 12, 2021
Modeling the effect of vaccination on selection for antibiotic resistance in <i>Streptococcus pneumonia</i> <i>e</i>
Nicholas G Davies, Stefan Flasche, Mark Jit, et al.
BMJ (Clinical Research Ed.)
|
January 9, 2015
Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model
Mark Jit, Marc Brisson, Jean-François Laprise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 8, 2020
Optimizing Benefits of Testing Key Workers for Infection with SARS-CoV-2: A Mathematical Modeling Analysis
Frank G Sandmann, Peter J White, Mary Ramsay, et al.
European Journal of Public Health
|
October 24, 2017
Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England
Diana Mendes, David Mesher, Angela Pista, et al.
Page
of 41
Search research articles
Search
Showing results (51-60 of 407) with videos related to
Sort By:
Page
of 41
BMC Health Services Research
|
May 17, 2017
Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study
Hoang Van Minh, Nguyen Thi Tuyet My, Mark Jit
Eclinicalmedicine
|
April 30, 2024
Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study
Kaja Abbas, Katelyn Jison Yoo, Kiesha Prem, et al.
NPJ Vaccines
|
February 1, 2025
A systematised review and evidence synthesis on the broader societal impact of vaccines against Salmonella
Ezgi Dilek Demirtas, Rosanna Barnard, Jungseok Lee, et al.
Vaccine
|
June 22, 2017
Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis
Sara L Bissett, Anna Godi, Mark Jit, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
May 21, 2021
The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant
David Hodgson, Stefan Flasche, Mark Jit, et al.
Vaccines
|
July 27, 2024
Inequitable Distribution of Global Economic Benefits from Pneumococcal Conjugate Vaccination
Fulgence Niyibitegeka, Fiona M Russell, Mark Jit, et al.
Science Translational Medicine
|
August 12, 2021
Modeling the effect of vaccination on selection for antibiotic resistance in <i>Streptococcus pneumonia</i> <i>e</i>
Nicholas G Davies, Stefan Flasche, Mark Jit, et al.
BMJ (Clinical Research Ed.)
|
January 9, 2015
Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model
Mark Jit, Marc Brisson, Jean-François Laprise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 8, 2020
Optimizing Benefits of Testing Key Workers for Infection with SARS-CoV-2: A Mathematical Modeling Analysis
Frank G Sandmann, Peter J White, Mary Ramsay, et al.
European Journal of Public Health
|
October 24, 2017
Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England
Diana Mendes, David Mesher, Angela Pista, et al.
Page
of 41